Sg3 Management, LLC Nektar Therapeutics Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $332,800 - $1.1 Million	80,000 Added 1600.0%	85,000 $458,000
Q4 2021 Feb 15, 2022	SELL	$10.83 - $18.41 $243,675 - $414,225	-22,500 Reduced 81.82%	5,000 $68,000
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $118,275 - $142,725	7,500 Added 37.5%	27,500 $468,000
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $331,800 - $495,800	20,000 New	20,000 $332,000

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.